北京大学学报(医学版) ›› 2019, Vol. 51 ›› Issue (4): 646-652. doi: 10.19723/j.issn.1671-167X.2019.04.009

• 论著 • 上一篇    下一篇

肾输尿管全长切除术两种不同术式的双中心疗效对比

吴进锋1,林榕城2,林友成1,蔡旺海1,朱庆国1,方冬2,熊耕砚2,张雷2,周利群2,叶烈夫1,(),李学松2,()   

  1. 1. 福建医科大学省立临床医学院,福建省立医院,福建省立金山医院泌尿外科, 福州 350001
    2. 北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿男性生殖系肿瘤研究中心, 北京 100034
  • 收稿日期:2019-03-20 出版日期:2019-08-18 发布日期:2019-09-03
  • 通讯作者: 叶烈夫,李学松 E-mail:yeliefu@126.com;pineneedle@sina.com
  • 基金资助:
    福建省卫生厅青年科研基金(2012-2-3)

Comparison of efficacy and safety between two different methods of nephroureterectomy in two centers

Jin-feng WU1,Rong-cheng LIN2,You-cheng LIN1,Wang-hai CAI1,Qing-guo ZHU1,Dong FANG2,Geng-yan XIONG2,Lei ZHANG2,Li-qun ZHOU2,Lie-fu YE1,(),Xue-song LI2,()   

  1. 1. Department of Urology, Provincial Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Provicial Jinshan Hospital,Fuzhou, 350001, China
    2. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
  • Received:2019-03-20 Online:2019-08-18 Published:2019-09-03
  • Contact: Lie-fu YE,Xue-song LI E-mail:yeliefu@126.com;pineneedle@sina.com
  • Supported by:
    Supported by the Youth Project of the Health Commission of Fujian Province(2012-2-3)

摘要:

目的:比较经腹完全腹腔镜肾输尿管全长切除术(complete transperitoneal laparoscopic nephroureterectomy, CTNU)和传统后腹腔镜肾输尿管全长切除术(traditional retroperitoneoscopic nephroureterectomy, TRNU)治疗上尿路尿路上皮癌(upper urinary tract urothelial carcinoma, UTUC)的手术安全性和疗效。方法:收集2011年1月至2018年12月期间在北京大学第一医院泌尿外科和福建省立医院泌尿外科接受CTNU和TRNU手术治疗的UTUC病例,比较两种手术方式患者在临床资料、围术期参数、术后随访结果等方面的差异。结果:最终共纳入病例266例,其中CTNU组94例,TRNU组172例。与CTNU组相比,TRNU组左侧病变比例更大(P<0.05)。两组患者年龄、性别分布、体重指数(body mass index,BMI)、美国麻醉医师学会评分(American society of anesthesiologists score, ASA score)、肿瘤所在侧别等方面均差异无统计学意义(P>0.05)。所有病例均完成手术,TRNU中有1例因左肾动脉损伤加行开放血管修补术。CTNU组手术时间为(202.9±76.7) min、术中出血量(68.4±73.3) mL、术后引流管留置天数(3.9±1.5) d、引流液总量(181.7±251.5) mL、术后住院天数(7.8±4.1) d;TRNU组手术时间为(203.5±68.7) min、术中出血量(130.2±252.1) mL、术后引流管留置天数(4.3±1.6) d、引流液总量(179.1±167.5) mL、术后住院天数(8.2±3.7) d。CTNU组术中出血量少于TRNU组,且差异有统计学意义(P=0.005)。中位随访时间39个月(1~88个月),TRNU组的5年总体生存率(overall survival, OS)、肿瘤特异性生存率(cancer specific survival, CSS)、无膀胱复发生存率(intra-vesical recurrence free survival, IvRFS)、无病生存率(disease free survival, DFS)分别为75.6%、86.9%、73.8%、57.5%;CTNU组的5年OS、CSS、IvRFS、DFS分别为66.3%、83.5%、75.9%、58.6%,两组间差异均无统计学意义。结论:CTNU手术是一种安全有效的手术治疗方式,但尚需更进一步的前瞻性随机对照研究加以证实。

关键词: 上尿路, 尿路上皮癌, 肾输尿管全长切除术

Abstract:

Objective: To compare the efficacy and safety of complete transperitoneal laparoscopic nephroureterectomy (CTNU) and traditional retroperitoneoscopic nehroureterectomy (TRNU) for the management of upper urinary tract urothelial carcinoma(UTUC).Methods: We retrospectively collected the clinical data of UTUC patients who underwent CTNU or TRNU surgery from January 2011 to December 2018 in Peking University First Hospital and Fujian Provincial Hospital, and compared the clinical characteristics, perioperative parameters, and follow-up results between the CTNU and TRNU surgeries.Results: Finally, a total of 266 cases were included, with 94 cases in the CTNU group and 172 cases in the TRNU group. The proportion of left side lesions was bigger in TRNU group when compared with CTNU group (P<0.05). No significant differences were observed in clinical characteristics, such as age, gender, body mass index(BMI), American society of anesthesiologists score(ASA score) and tumor laterality. All surgery procedures were completed. The vascular resparing was performed by reason that left arteria renalis was injured accidently during surgical operation in one case of TRNU group. No serious complications were observed in both CTNU and TRNU groups. In CTNU group, operating time was (202.9±76.7) min, estimated blood loss was (68.4±73.3) mL, drainage duration was (3.9±1.5) d, drainage volume was (181.7±251.5) mL, and postoperative hospital stay was (7.8±4.1) d. In TRNU group, operating time was (203.5±68.7) min, estimated blood loss was (130.2±252.1) mL, drainage duration was (4.3±1.6) d, drainage volume was (179.1±167.5) mL, and postoperative hospital stay was (8.2±3.7) d. The estimated blood loss in CTNU group was significantly less than that in TRNU group (P =0.005).The median follow-up time was 39 months (range: 1-88 months). The 5-year overall survival rate (OS), cancer specific survival rate (CSS), intra-vesical recurrence free survival rate (IvRFS), disease free survival rate (DFS) of CTNU group was 75.6%, 86.9%, 73.8%, 57.5%, respectively. The OS, CSS, IvRFS and DFS of TRNU group was 66.3%, 83.5%, 75.9%, 58.6%, respectively.No significant differences were observed in the OS, CSS, IvRFS and DFS between the CTNU and TRNU groups.Conclusion: CTNU technique is a safe and effective surgical option, and further prospective randomized controlled trial is needed for further evaluation.

Key words: Upper urinary tract, Urothelial carcinoma, Nephroureterectomy

中图分类号: 

  • R737.11

图1

上腹部“四点钻石形”布局"

图2

上腹部“四点菱形”布局"

表1

所有病例的临床及病理资料"

Items TRNU group(n=172) CTNU group(n=94) P value
Age/years, x?±s 67.1±11.5 66.0±9.2 0.437
Gender, n(%) 0.650
Male 92 (53.5) 53 (56.4)
Female 80 (46.5) 41 (43.6)
BMI(256 patients available)/(kg/m2), x?±s 24.4±2.9 23.9±3.4 0.342
Side, n(%) 0.001
Left 107 (62.2) 39 (41.5)
Right 65 (37.8) 55 (58.5)
Ureteroscopy, n(%) 0.517
Yes 29 (16.9) 13 (13.8)
No 143 (83.1) 81 (86.2)
ASA score (225 patients available), n(%) 0.085
1 6 (4.1) 9 (11.4)
2 112 (76.7) 59 (74.7)
3 28 (19.2) 11 (13.9)
Concomitant bladder cancer (206 patients available), n(%) 0.987
Yes 16 (11.2) 7 (11.1)
No 127 (88.8) 56 (88.9)
T stage, n(%) 0.523
Ta 4 (2.3) 2 (2.1)
T1 67 (39.0) 30 (31.9)
T2 50 (29.1) 30 (31.9)
T3 44 (25.6) 31 (33.0)
T4 5 (2.9) 1 (1.1)
Grade, n(%) 0.103
G1 51 (29.7) 37 (39.4)
G2 83 (48.3) 45 (47.9)
G3 38 (22.1) 12 (12.8)
Lymph node invasion, n(%) 0.403
N+ 7 (4.1) 6 (6.4)
N0 or Nx 165 (95.9) 88 (93.6)

表2

所有病例的术中和术后情况"

Items TRNU group (n=172) CTNU group (n=94) P value
Operating time/min,x?±s 203.5±68.7 202.9±76.7 0.865
Estimated blood loss/mL,x?±s 130.2±252.1 68.4±73.3 0.005
Drainage duration/d,x?±s 4.3±1.6 3.9±1.5 0.090
Drainage volume/mL,x?±s 179.1±167.5 181.7±251.5 0.150
Postoperative hospital stay/d,x?±s 8.2±3.7 7.8±4.1 0.075
Perioperative complications,n/Clavien-Dindo grading 0.972
Intra-vesical hemorrhage 2/Ⅱ 1/Ⅱ
Reanal fossa hemorrhage 1/Ⅱ
Lymphatic fluid leakage 1/Ⅰ 1/Ⅰ
Ileus 1/Ⅱ

图3

两组病例术后生存情况"

[1] Siegel RL, Miller KD, Jemal A , et al. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016,66(1):7-30.
[2] Roupret M, Babjuk M, Comperat E , et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update[J]. Eur Urol, 2017,73(1):111-122.
[3] 刘荣耀, 赵鹏举, 李学松 , 等. 经腹腔完全腹腔镜肾输尿管全长切除术治疗上尿路尿路上皮癌[J]. 北京大学学报(医学版), 2011,43(4):531-534.
[4] 李学松, 洪鹏, 丁光璞 , 等. 经腹完全腹腔镜肾输尿管全长切除术的关键技术总结(附光盘)[J]. 现代泌尿外科杂志, 2018,23(10):728-731.
[5] Clayman RV, Kavoussi LR, Figenshau RS , et al. Laparoscopic nephroureterectomy: initial clinical case report[J]. J Laparoendosc Surg, 1991,1(6):343-349.
[6] Ni S, Tao W, Chen Q , et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies[J]. Eur Urol, 2012,61(6):1142-1153.
[7] Ghazi A, Shefler A, Gruell M , et al. A novel approach for a complete laparoscopic nephroureterectomy with bladder cuff excision[J]. J Endourol, 2010,24(3):415-419.
[8] Mcdonald DF . Intussusception ureterectomy: a method of removal of the ureteral stump at time of nephrectomy without an additional incision[J]. Surg Gynecol Obstet, 1953,97(5):565-568.
[9] Gill IS, Soble JJ, Miller SD , et al. A novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy[J]. J Urol, 1999,161(2):430-434.
[10] Gill IS, Sung GT, Hobart MG , et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the cleveland clinic experience[J]. J Urol, 2000,164(5):1513-1522.
[11] Tsivian A, Benjamin S, Sidi AA . A sealed laparoscopic nephroureterectomy: a new technique[J]. Eur Urol, 2007,52(4):1015-1019.
[12] Jarrett TW, Chan DY, Cadeddu JA , et al. Laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract[J]. Urology, 2001,57(3):448-453.
[13] Yoshino Y, Ono Y, Hattori R , et al. Traditional retroperitoneoscopic nephroureterectomy for transitional cell carcinoma of the renal pelvis and ureter: Nagoya experience[J]. Urology, 2003,61(3):533-538.
[14] Hsi RS, Saint-Elie DT, Zimmerman GJ , et al. Mechanisms of hemostatic failure during laparoscopicnephrectomy: review of Food and Drug Administration database[J]. Urology, 2007,70(5):888-892.
[15] Liu P, Fang D, Xiong G , et al. A novel and simple modification for management of distal ureter during laparoscopic nephroureterectomy without patient repositioning a bulldog clamp technique and description of modified port placement[J]. J Endourol, 2016,30(2):195-200.
[16] Abe T, Shinohara N, Harabayashi T , et al. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study[J]. BJU Int, 2008,102(5):576-580.
[17] Kondo T, Tanabe K . Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract[J]. Int J Urol, 2012,19(8):710-721.
[1] 程嗣达,李新飞,熊盛炜,樊书菠,王杰,朱伟杰,李子奡,丁光璞,俞婷,李万强,孙永明,杨昆霖,张雷,郝瀚,李学松,周利群. 机器人辅助腹腔镜上尿路修复手术:单一术者108例经验总结[J]. 北京大学学报(医学版), 2020, 52(4): 771-779.
[2] 张军晖,蒋一航,蒋宇光,张际青,康宁. 双侧同步内镜手术治疗双侧上尿路结石的临床效果[J]. 北京大学学报(医学版), 2020, 52(4): 672-677.
[3] 黄炳伟,王杰,张鹏,李喆,毕泗成,王强,岳才博,杨昆霖,李学松,周利群. 吲哚菁绿在复杂上尿路修复手术中的应用[J]. 北京大学学报(医学版), 2020, 52(4): 651-656.
[4] 关豹,翁迈,凡航,彭鼎,方冬,熊耕砚,李学松,周利群. 术前贫血对上尿路尿路上皮癌预后的影响: 单中心686例患者回顾性研究[J]. 北京大学学报(医学版), 2019, 51(6): 1056-1061.
[5] 马闰卓,夏海缀,陆敏,张智荧,张启鸣,卢剑,王国良,马潞林. 输尿管镜活体组织检查对上尿路尿路上皮癌根治性手术的影响[J]. 北京大学学报(医学版), 2019, 51(4): 665-672.
[6] 程嗣达,李万强,穆莉,丁光璞,张博,谌诚,应泽伟,杨昆霖,郝瀚,李学松,周利群. 全腹膜外途径膀胱瓣肾盂吻合自体肾移植术在上尿路尿路上皮癌治疗中的应用[J]. 北京大学学报(医学版), 2019, 51(4): 758-763.
[7] 丁光璞,程嗣达,方冬,杨昆霖,李学松,周辉霞,张骞,叶雄俊,周利群. 上尿路微创手术的技术改良[J]. 北京大学学报(医学版), 2019, 51(4): 610-614.
[8] 马闰卓,邱敏,何为,杨斌,夏海缀,邹达,陆敏,马潞林,卢剑. 输尿管镜活检可协助上尿路尿路上皮癌危险分层[J]. 北京大学学报(医学版), 2017, 49(4): 632-637.
[9] 关豹,曹振朋,彭鼎,李一帆,詹永豪,刘漓波,何世明,熊耕砚,李学松,周利群. T2N0M0期上尿路尿路上皮癌患者预后相关因素分析:单中心235例患者回顾性研究[J]. 北京大学学报(医学版), 2017, 49(4): 603-607.
[10] 柳家园,彭翔,宁向辉,李腾,彭双鹤,王江宜,刘圣杰,丁义,蔡林,龚侃. 尿脱落细胞荧光原位杂交检查阳性在尿路上皮癌中的临床价值[J]. 北京大学学报(医学版), 2017, 49(4): 585-589.
[11] 李秀楠,刘爱蕙,唐欣,任宇. 尿路上皮癌相关1基因通过竞争性抑制miR-18a增强乳腺癌细胞的他莫昔芬治疗耐药[J]. 北京大学学报(医学版), 2017, 49(2): 295-302.
[12] 周利群, 李学松, 熊耕砚. 中国人群上尿路尿路上皮癌新进展[J]. 北京大学学报(医学版), 2014, 46(4): 504-506.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[8] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .